Migraine after electroconvulsive therapy
Abstract
The first detailed case report of recurrent common migraine after electroconvulsive therapy (ECT) is presented; it involves a 52-year-old woman with major depressive disorder. The migraine symptoms corresponded to those of the infrequent spontaneous migraine attacks she had. After a change to propofol as the anesthetic because of methohexital intolerance, the migraine attacks ceased, apparently due to seizure generalization being inhibited by propofol. In patients with migraine, ECT may be expected to trigger a migraine attack, probably in the same way as spontaneous seizures. The possible reasons and significance are discussed.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.